Abstract
Disorders of the mineral balance often determine the symptoms, the severity of the course and the prognosis of many diseases. Primary hyperparathyroidism (PHPT) is a common endocrine disease caused by increased secretion of parathyroid hormone as a result of primary damage to the parathyroid glands. Diagnosis of PHPT is often difficult. Clinical signs of PHPT appear months or years after the onset of the disease, however, the presence of hypercalcemia serves as an early indication of the disease of the thyroid gland. Often, patients are observed for a long time by related specialists (rheumatologists, traumatologists-orthopedists, oncologists), which gives rise to a lot of problems consisting in the lack of adequate treatment and its result, the progression of the disease, disability, and a decrease in the quality of life. Often, patients are observed for a long time by related specialists (rheumatologists, orthopedic traumatologists, oncologists) under the “masks” of various pathologies (osteoporosis, recurrent urolithiasis, etc.), which gives rise to a lot of problems, consisting in an erroneous diagnosis, lack of adequate treatment and its result, progression of the disease, disability, and a decrease in the quality of life. Late diagnosis of PHPT leads to the development of severe complications (osteoporetic fractures, renal failure) and an increased risk of premature death. A clinical case of late diagnosis of PHPT at the stage of pronounced bone complications of the disease, which proceeded under the guise of osteoarthritis, is considered. According to the results of laboratory and instrumental studies, the following were revealed: hypercalcemia, a significant increase in the concentration of PTH, adenoma of the left lower parathyroid gland, hyperparathyroid osteodystrophy, and a decrease in bone mineral density. Surgical treatment was performed – selective parathyroidectomy with the development of hypocalcemia in the early postoperative period, which was stopped by taking calcium supplements and active vitamin D metabolites and is designed to help practitioners of various specialties to understand the issues of diagnosis of PHPT and effective care for patients.
Reference17 articles.
1. Клинические рекомендации. Первичный гиперпаратиреоз. Разработчик клинической рекомендации: Российская ассоциация эндокринологов, Ассоциация эндокринных хирургов. М., 2020 г.; с. 13-4 [Klinicheskiie rekomendatsii. Pervichnyi giperparatireoz. Razrabotchik klinicheskoi rekomendatsii: Rossiiskaia assotsiatsiia endokrinologov, Assotsiatsiia endokrinnykh khirurgov. Moscow, 2020; p. 13-4 (in Russian)].
2. Hypercalcaemia and primary hyperparathyroidism
3. Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993-2001: An Update on the Changing Epidemiology of the Disease
4. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK
5. Normocalcemic Hyperparathyroidism: A Heterogeneous Disorder Often Misdiagnosed?